Form 4: AMREP CEO Christopher Vitale Granted 8,000 Restricted Shares

AMREP Corporation's President and CEO, Christopher V. Vitale, was granted 8,000 shares of restricted common stock under the company's 2016 Equity Compensation Plan, vesting over three years.

Summary

• Christopher V. Vitale, President and CEO of AMREP Corporation (AXR), was granted 8,000 shares of common stock.
• The transaction date for this acquisition was July 17, 2025.
• The shares were granted as restricted stock under the AMREP Corporation 2016 Equity Compensation Plan at a price of $0 per share.
• Following this transaction, Mr. Vitale beneficially owns 117,200 shares of common stock.
• The restricted stock will vest in three tranches: 2,666 shares on July 17, 2026, 2,667 shares on July 17, 2027, and 2,667 shares on July 17, 2028.
• Vesting is contingent upon Mr. Vitale's continued employment with AMREP Corporation on each respective vesting date.

Sentiment

Score: 7

Explanation: The grant of restricted stock to the CEO is a positive for corporate governance and long-term alignment of management interests with shareholders, serving as a retention incentive. It is a routine compensation event.

Positives

• The grant of restricted stock aligns the CEO's long-term interests with those of shareholders, as the value of the compensation is tied to the company's stock performance.
• The multi-year vesting schedule acts as a strong retention incentive for the President and CEO, ensuring leadership continuity.

Risks

• The vesting of the restricted stock is subject to the continued employment of Mr. Vitale, meaning the shares could be forfeited if employment ceases before vesting dates.

Future Outlook

The grant of restricted stock with a multi-year vesting schedule indicates a strategic move to retain key executive talent and align their long-term performance incentives with shareholder value creation.

Industry Context

The grant of restricted stock to a CEO is a common practice in corporate compensation structures across various industries, designed to incentivize long-term performance and executive retention by linking compensation directly to company equity.

Comparison to Industry Standards

• The use of restricted stock as a component of executive compensation is a widely accepted practice, aligning with global benchmarks for corporate governance and incentive structures.
• The vesting schedule over multiple years is standard for such grants, providing a sustained incentive for executive performance and retention, comparable to practices at other publicly traded companies.

Corporate Governance

Related Party Transactions

• The grant of restricted stock to Christopher V. Vitale, the President and CEO, constitutes a related party transaction as it involves compensation from the company to a key executive.

Stakeholder Impact

• Shareholders: Benefits from increased alignment of the CEO's interests with long-term stock performance and retention of key leadership.
• Employees: The CEO's continued commitment may foster stability and strategic direction.
• Management: The CEO receives a significant equity incentive tied to future performance and continued employment.

Next Steps

• Vesting of 2,666 restricted shares on July 17, 2026.
• Vesting of 2,667 restricted shares on July 17, 2027.
• Vesting of 2,667 restricted shares on July 17, 2028.

Key Dates

Recommendation

Keywords

AMREP Corporation, AXR, Christopher V. Vitale, Restricted Stock, Equity Compensation Plan, CEO Compensation, Insider Grant, Form 4, Stock Vesting